Literature DB >> 2966094

Down's syndrome: a pathology involving the lack of balance of reactive oxygen species.

J Kedziora1, G Bartosz.   

Abstract

Mongolism, or Down's syndrome (DS) is an inborn pathology due to trisomy 21. Apart from mental deficiency and anatomical abnormalities, premature aging is characteristic for this disease. This paper mainly reviews data on the generation of reactive oxygen species (ROS) and antioxidative defense mechanisms in DS, and on the sensitivity of DS cells to model sources of ROS. Changes in the antioxidative defense of DS cells are due mainly to the location of the gene for (Cu,Zn)-superoxide dismutase on chromosome 21. It is suggested that a disturbance of balance of ROS may be a key point in the pathogenesis of DS.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2966094     DOI: 10.1016/0891-5849(88)90052-4

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  15 in total

1.  Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease.

Authors:  Fabio Di Domenico; Gilda Pupo; Cesare Mancuso; Eugenio Barone; Francesca Paolini; Andrea Arena; Carla Blarzino; Frederick A Schmitt; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.

Authors:  Giovanna Cenini; Amy L S Dowling; Tina L Beckett; Eugenio Barone; Cesare Mancuso; Michael Paul Murphy; Harry Levine; Ira T Lott; Frederick A Schmitt; D Allan Butterfield; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2011-10-08

3.  Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation.

Authors:  Ira T Lott; Eric Doran; Vinh Q Nguyen; Anne Tournay; Elizabeth Head; Daniel L Gillen
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

4.  Superoxide dismutase 1 modulates expression of transferrin receptor.

Authors:  Ruth Danzeisen; Tilmann Achsel; Ulrich Bederke; Mauro Cozzolino; Claudia Crosio; Alberto Ferri; Malte Frenzel; Edith Butler Gralla; Lea Huber; Albert Ludolph; Monica Nencini; Giuseppe Rotilio; Joan Selverstone Valentine; Maria Teresa Carrì
Journal:  J Biol Inorg Chem       Date:  2006-04-26       Impact factor: 3.358

Review 5.  Antioxidants in Down syndrome.

Authors:  Ira T Lott
Journal:  Biochim Biophys Acta       Date:  2011-12-21

Review 6.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

7.  Importance of mitochondrial superoxide dismutase expression in insulin-producing cells for the toxicity of reactive oxygen species and proinflammatory cytokines.

Authors:  S Lortz; E Gurgul-Convey; S Lenzen; M Tiedge
Journal:  Diabetologia       Date:  2005-06-29       Impact factor: 10.122

8.  Superoxide dismutase, lipid peroxidation, and bell-shaped dose response curves.

Authors:  Joe M McCord
Journal:  Dose Response       Date:  2008-08-06       Impact factor: 2.658

9.  Antioxidant activities and determination of phenolic compounds isolated from oriental plums (Soldam, Oishiwase and Formosa).

Authors:  Se-Na Kim; Mee-Ree Kim; Soo-Muk Cho; So-Young Kim; Jung-Bong Kim; Young-Sook Cho
Journal:  Nutr Res Pract       Date:  2012-08-31       Impact factor: 1.926

10.  Extensive natural variation for cellular hydrogen peroxide release is genetically controlled.

Authors:  Homa Attar; Karen Bedard; Eugenia Migliavacca; Maryline Gagnebin; Yann Dupré; Patrick Descombes; Christelle Borel; Samuel Deutsch; Holger Prokisch; Thomas Meitinger; Divya Mehta; Erich Wichmann; Jean Maurice Delabar; Emmanouil T Dermitzakis; Karl-Heinz Krause; Stylianos E Antonarakis
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.